The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pascual, D. W.
Right arrow Articles by Hillemeyer, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pascual, D. W.
Right arrow Articles by Hillemeyer, P.
The Journal of Immunology, 1998, 160: 4465-4472.
Copyright © 1998 by The American Association of Immunologists

Repeated Intratracheal Instillations of Nonreplicating Adenovirus 2 Vector Attenuate CTL Responses and IFN-{gamma} Production1

David W. Pascual2, Nancy Walters and Peter Hillemeyer

Veterinary Molecular Biology, Montana State University, Bozeman, MT 59717

The proposed usage of replication-deficient adenovirus (Ad) vectors for corrective gene therapy or for mucosal immunization has been limited in part by the host reactivity to the Ad vector, thus limiting repeated Ad instillations. We have recently shown that the reactivity to the Ad vector is in large part due to increased CD4+ Th1 and Th2 responses as well as elevated IgG and mucosal IgA responses. It has been recently proposed that the diminution of transgene expression in respiratory epithelia was due to increased CTL reactivity to expressed Ad proteins. Herein, we report that repeated intratracheal delivery of a second generation Ad2 vector into mice results in no detectable CTL activity in freshly isolated lymphoid cells from lungs, lower respiratory lymph nodes, or spleens or after in vitro restimulation. In contrast, a single dose of Ad2 vector did elicit a robust CTL response. This attenuation of CTL activity was long lived and was not affected by macrophage depletion or due to a reduction in CD4+ or CD8+ T cells. Examination of cytokine production via MHC class I or class II restimulation by lymphoid cells from three intratracheally treated mice showed an attenuation in the production of IFN-{gamma} by as much as 110-fold. This reduction in IFN-{gamma} could not be attributed to increased IL-4 or IL-10 production. Thus, this study shows that the CTL response to Ad vectors is attenuated upon repeated administration.




This article has been cited by other articles:


Home page
J. Virol.Home page
J. D. Finn, J. Bassett, J. B. Millar, N. Grinshtein, T. C. Yang, R. Parsons, C. Evelegh, Y. Wan, R. J. Parks, and J. L. Bramson
Persistence of Transgene Expression Influences CD8+ T-Cell Expansion and Maintenance following Immunization with Recombinant Adenovirus
J. Virol., December 1, 2009; 83(23): 12027 - 12036.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. W. Pascual, X. Wang, I. Kochetkova, G. Callis, and C. Riccardi
The Absence of Lymphoid CD8+ Dendritic Cell Maturation in L-Selectin-/- Respiratory Compartment Attenuates Antiviral Immunity
J. Immunol., July 15, 2008; 181(2): 1345 - 1356.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Wang, D. M. Hone, A. Haddad, M. T. Shata, and D. W. Pascual
M Cell DNA Vaccination for CTL Immunity to HIV
J. Immunol., November 1, 2003; 171(9): 4717 - 4725.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. K. Dybing, N. Walters, and D. W. Pascual
Role of Endogenous Interleukin-18 in Resolving Wild-Type and Attenuated Salmonella typhimurium Infections
Infect. Immun., December 1, 1999; 67(12): 6242 - 6248.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.